Kallioniemi OP - Search Results

1

Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.

Koivisto P, Visakorpi T, Kallioniemi OP. Koivisto P, et al. Among authors: kallioniemi op. Scand J Clin Lab Invest Suppl. 1996;226:57-63. Scand J Clin Lab Invest Suppl. 1996. PMID: 8981668 Review.

2

Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.

Koivisto P, Hyytinen E, Palmberg C, Tammela T, Visakorpi T, Isola J, Kallioniemi OP. Koivisto P, et al. Among authors: kallioniemi op. Am J Pathol. 1995 Dec;147(6):1608-14. Am J Pathol. 1995. PMID: 7495286 Free PMC article.

3

In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. Visakorpi T, et al. Among authors: kallioniemi op. Nat Genet. 1995 Apr;9(4):401-6. doi: 10.1038/ng0495-401. Nat Genet. 1995. PMID: 7795646

4

Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi OP. Koivisto P, et al. Among authors: kallioniemi op. Cancer Res. 1997 Jan 15;57(2):314-9. Cancer Res. 1997. PMID: 9000575

5

Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.

Palmberg C, Koivisto P, Hyytinen E, Isola J, Visakorpi T, Kallioniemi OP, Tammela T. Palmberg C, et al. Among authors: kallioniemi op. Eur Urol. 1997;31(2):216-9. doi: 10.1159/000474453. Eur Urol. 1997. PMID: 9076469

6

Androgen receptor gene and hormonal therapy failure of prostate cancer.

Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP. Koivisto P, et al. Among authors: kallioniemi op. Am J Pathol. 1998 Jan;152(1):1-9. Am J Pathol. 1998. PMID: 9422516 Free PMC article. Review.

7

Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia.

Koivisto PA, Schleutker J, Helin H, Ehren-van Eekelen C, Kallioniemi OP, Trapman J. Koivisto PA, et al. Among authors: kallioniemi op. Clin Cancer Res. 1999 Nov;5(11):3578-82. Clin Cancer Res. 1999. PMID: 10589774

8

Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.

Palmberg C, Koivisto P, Kakkola L, Tammela TL, Kallioniemi OP, Visakorpi T. Palmberg C, et al. Among authors: kallioniemi op. J Urol. 2000 Dec;164(6):1992-5. J Urol. 2000. PMID: 11061898

9

Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.

Mononen N, Syrjäkoski K, Matikainen M, Tammela TL, Schleutker J, Kallioniemi OP, Trapman J, Koivisto PA. Mononen N, et al. Among authors: kallioniemi op. Cancer Res. 2000 Nov 15;60(22):6479-81. Cancer Res. 2000. PMID: 11103816

10

Androgen regulation of micro-RNAs in prostate cancer.

Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G, Visakorpi T. Waltering KK, et al. Among authors: kallioniemi op. Prostate. 2011 May;71(6):604-14. doi: 10.1002/pros.21276. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters